首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1606541

全球動態心電圖分析系統與軟體市場 - 2024-2031

Global Holter Analysis System & Software market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球動態心電圖分析系統與軟體市場規模達12.4億美元，預計2031年將達到28.4億美元，2024-2031年預測期間複合年成長率為10.9%。

Holter 分析系統是一種醫療工具，可在 24 至 48 小時內連續監測心臟的電活動。它透過患者胸部的電極捕捉即時心電圖資料，識別和分析標準心電圖可能無法檢測到的心臟不規則現象。 Hillrom 和飛利浦開發的現代動態心電圖系統使用先進的軟體進行資料分析和報告，允許醫療保健提供者從遠端站點導入記錄並安全地匯出電子報告，確保符合 HIPAA 法規。顯著的功能包括掃描模式、雙向介面和複雜的訊號處理演算法，以提高診斷準確性。

市場動態：

驅動程式和限制

與穿戴式組件的日益整合

全球動態心電圖分析系統和軟體市場是由與穿戴式組件的日益整合所推動的。注重健康的消費者擴大使用穿戴式裝置進行健身和健康監測，這讓患者能夠監測自己的心臟健康狀況以及其他健康指標，從而增強使用者體驗。這種整合不僅提高了動態心電圖監測系統在數位健康生態系統中的可見性，而且還促進了患者更大程度的參與和遵守監測協議。隨著患者更主動管理自己的健康，對先進動態心電圖監測解決方案的需求預計將會上升，從而推動市場成長。

例如，2024 年 8 月，領先的數位醫療保健公司 iRhythm Technologies 在奧地利、荷蘭、西班牙和瑞士推出了 Zio 監視器和長期連續 (LTCM) 動態心電圖監護服務。 Zio 監視器和ZEUS 系統於2023 年12 月根據醫療器材法規獲得了CE 標誌。這是一項重大進步。

低報銷政策

由於動態心電圖監測程序的報銷政策較低，全球動態心電圖分析系統和軟體市場面臨重大挑戰。在許多地區，特別是在發展中國家，動態心電圖監測的保險範圍有限或根本不存在，這對醫療保健提供者和患者造成了財務障礙。這阻礙了動態心電圖監測系統的採用，導致許多機構選擇成本較低的替代方案或傳統方法。由於財務限制，有必要重新評估動態心電圖監測系統的價值主張，以確保其被認可為有效的心臟護理和管理所必需的。

有關此報告的更多詳細資訊 - 索取樣本

The Holter Analysis System is a medical tool that continuously monitors the heart's electrical activity over 24 to 48 hours. It captures real-time ECG data through electrodes on the patient's chest, identifying and analyzing cardiac irregularities that may not be detected during standard ECGs. Modern Holter systems, developed by Hillrom and Philips, use advanced software for data analysis and reporting, allowing healthcare providers to import recordings from remote sites and export electronic reports securely, ensuring compliance with HIPAA regulations. Notable features include scanning modes, bidirectional interfaces, and sophisticated signal processing algorithms for improved diagnostic accuracy.

Market Dynamics: Drivers & Restraints

Growing Integration with Wearable Component

The global holter analysis system and software market is driven by the increasing integration with wearable Component. Health-conscious consumers are increasingly using wearable devices for fitness and health monitoring, which enhances the user experience by allowing patients to monitor their heart health alongside other health metrics. This convergence not only increases the visibility of Holter monitoring systems in the digital health ecosystem but also promotes greater patient engagement and adherence to monitoring protocols. As patients become more proactive in managing their health, the demand for advanced Holter monitoring solutions is expected to rise, driving market growth.

For instance, in August 2024, iRhythm Technologies, a leading digital health care company, has launched its Zio monitor and long-term continuous (LTCM) ambulatory ECG monitoring service in Austria, the Netherlands, Spain, and Switzerland. The Zio monitor and ZEUS system received CE Marking Under Medical Device Regulation in December 2023. The LTCM service offers up to 14 days of continuous, uninterrupted ECG monitoring, a significant advancement in these countries compared to older Holter monitoring services.

Low Reimbursement Policies

The global Holter Analysis System and Software market faces a significant challenge due to low reimbursement policies for Holter monitoring procedures. In many regions, particularly in developing countries, insurance coverage for Holter monitoring is limited or non-existent, creating financial barriers for healthcare providers and patients. This discourages the adoption of Holter monitoring systems, leading many facilities to opt for less costly alternatives or traditional methods. The financial constraints necessitate a reevaluation of the Holter monitoring system's value proposition to ensure its recognition as essential for effective cardiac care and management.

For more details on this report - Request for Sample

Segment Analysis

The global holter analysis system & software market is segmented based on product type, component, application, end user and region.

Product type:

Wireless Holter Monitor segment is expected to dominate the holter analysis system & software market share

The wireless holter monitor segment holds a major portion of the holter analysis system & software market share and is expected to continue to hold a significant portion of the holter analysis system & software market share during the forecast period.

Surgical instruments are essential tools for various medical procedures, including routine surgeries and complex interventions. They ensure precision, efficiency, and safety. The increasing prevalence of chronic diseases and the number of surgical procedures worldwide have driven the demand for high-quality, specialized instruments. Technological advancements, such as titanium and stainless steel integration, have improved the durability, sterility, and ergonomics of these instruments. Disposable surgical instruments have also addressed concerns about cross-contamination and infection control. The focus on improving surgical outcomes and reducing patient recovery times has further highlighted the importance of surgical instruments in the Holter Analysis System & Software market.

For instance, in September 2022, Borsam Biomedical Instruments has introduced its wireless ECG monitors, the 'Wireless ECG Monitor Event Recorder' and 'ECG Holter Recorder', which allow individuals to monitor their heart health remotely from the hospital. The Event Recorder records ECG data while the Holter is designed for longer-term wear and attaches to the chest using stickers and three leads.

End User:

Hospitals segment is the fastest-growing segment in holter analysis system & software market share

The hospitals segment is the fastest-growing segment in the holter analysis system & software market share and is expected to hold the market share over the forecast period.

Hospitals are the primary users of holter analysis system and software. They are increasingly focusing on preventive cardiology initiatives to address the increasing prevalence of cardiovascular diseases. Holter monitoring systems are crucial for this, providing continuous data collection for early detection and management of cardiac abnormalities. This proactive approach enhances patient outcomes and optimizes treatment plans. Hospitals have advanced infrastructure and technology that facilitate the integration of Holter monitoring systems into clinical workflows, improving diagnostic accuracy and streamlining patient data management. This solidifies hospitals' central role in driving Holter monitoring solutions in the evolving healthcare landscape.

Geographical Analysis

North America is expected to hold a significant position in the holter analysis system & software market share

North America holds a substantial position in the holter analysis system & software market and is expected to hold most of the market share.

Among the factors propelling the holter analysis system and software market in North America is the increasing prevalence of cardiovascular diseases (CVDs) among their aging populations. Indeed, North America records one of the highest incidences of heart conditions and thus the necessity for improved monitoring for early detection and management. Additionally, Increased acceptance of remote monitoring technologies has emerged, as both patients and healthcare professionals seek more convenient ways to take care of and manage health problems instead of confined hospital settings. Modernization and sophistication have characterized the advancements with Holter monitoring devices in technical terms. Consequently, North America is set to maintain a stronghold in the market due to continued investment in healthcare infrastructure and innovation.

For instance, in May 2024, Vivalink, a leading provider of digital healthcare solutions, has launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.

Europe is growing at the fastest pace in the holter analysis system & software market

Europe holds the fastest pace in the holter analysis system & software market and is expected to hold most of the market share.

As life expectancy in various European countries increases, so does the number of health issues, especially those related to the heart, which require regular monitoring because of their age. According to the statistics presented by the European Union, the older population of 65 years and above comprises a significant share of its population. This translates into a growing demand for improved cardiac monitoring solutions like Holter systems. The modernization of healthcare facilities and improved service delivery in several European countries further enhance the availability and effectiveness of Holter monitoring technologies. The above considers changes in the demographical domain, however, growth in the market is witnessed by several challenges-for example, a shortage of skilled human resources to conduct accurate ECG analysis.

For instance, in November 2024, the medilogFD is a new SCHILLER 12-lead Holter ECG for spatial heart health analysis, offering a comprehensive assessment of cardiac ECG conditions. It detects atrial fibrillation/atrial flutter based on true P-wave analysis and can also provide additional respiratory information through the optional SpO2 sensor.

Competitive Landscape

The major global players in the holter analysis system & software market include GE Healthcare, Philips Healthcare, VitalConnect, Vivalink, Cardioline SpA, Schiller AG, Midmark Corporation, Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., iRhythm Technologies, Inc. among others.

Emerging Players

The emerging players in the holter analysis system & software market include LifeSignals, Inc, Bardy Diagnostics, Inc and among others.

Key Developments

In February 2024, UltraLinQ has launched its Holter Program during American Heart Month, featuring the UbiqVue Holter and ECG Interpretation Software. This innovative biosensor is designed to meet the needs of modern cardiology practices, making cardiac care seamless, accessible, and scalable. The Holter device and software are designed to manage ECG data and final reports.

Why Purchase the Report?

Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
Market Positioning: Analysis of product performance and growth potential for optimized strategies.
Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
Market Expansion: Strategies for entering new markets and forming partnerships.
Regional Opportunities: Identification of high-growth regions and investment prospects.
Supply Chain Optimization: Assessment of risks and distribution strategies.
Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
Post-Market Surveillance: Enhanced safety and access through post-market data.
Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global holter analysis system & software market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Integration with Wearable Component
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Wireless Holter Monitors*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wired Holter Monitors
6.4. Portable Holter Monitors
6.5. Ambulatory ECG Monitors

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Arrhythmia*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Atrial Fibrillation
7.4. Bradycardia and Tachycardia
7.5. Ischemic Heart Disease
7.6. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Cardiac Centers
8.5. Clinics
8.6. Home Care Settings

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Philips Healthcare
11.3. VitalConnect
11.4. Vivalink
11.5. Cardioline SpA
11.6. Schiller AG
11.7. Midmark Corporation
11.8. Nasiff Associates, Inc.
11.9. Biomedical Instruments Co., Ltd
11.10. iRhythm Technologies, Inc. (LIST NOT EXHAUSTIVE)